Journal article

Ibrutinib for patients with rituximab-refractory Waldenstrm's macro globulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial

Meletios A Dimopoulos, Judith Trotman, Alessandra Tedeschi, Jeff Rey V Matous, David Macdonald, Constantine Tam, Olivier Tournilhac, Shuo Ma, Albert Oriol, Leonard T Heffner, Chaim Shustik, Ramon Garcia-Sanz, Robert F Cornell, Carlos Fernandez de Larrea, Jorge J Castillo, Miquel Granell, Marie-Christine Kyrtsonis, Veronique Leblond, Argiris Symeonidis, Efstathios Kastritis Show all

The Lancet Oncology | ELSEVIER SCIENCE INC | Published : 2017